TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for BiomX Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-04 7:59 pm Unchanged |
2022-03-25 | 13G | BiomX Inc. PHGE |
TAKEDA PHARMACEUTICAL CO LTD | 147,829 4.960% |
0 (Unchanged) |
Filing |
| 2021-10-18 06:03 am Sale |
2021-10-14 | 13G | BiomX Inc. PHGE |
TAKEDA PHARMACEUTICAL CO LTD | 147,829 5.200% |
-99,265 (-40.17%) |
Filing |